| Literature DB >> 29753613 |
Suowen Xu1, Jaroslav Pelisek2, Zheng Gen Jin3.
Abstract
Atherosclerosis is a chronic inflammatory and lipid-depository disease that eventually leads to acute cardiovascular events. Emerging evidence supports that epigenetic processes such as DNA methylation, histone modification, and noncoding RNAs play an important role in plaque progression and vulnerability, highlighting the therapeutic potential of epigenetic drugs in cardiovascular therapeutics.Entities:
Keywords: DNA methylation; atherosclerosis; epigenetics; histone modification; therapeutics
Mesh:
Substances:
Year: 2018 PMID: 29753613 PMCID: PMC7202861 DOI: 10.1016/j.tem.2018.04.007
Source DB: PubMed Journal: Trends Endocrinol Metab ISSN: 1043-2760 Impact factor: 12.015